Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| D005264 | Femoral Fractures NIH | 1.00 |
| D050723 | Fractures, Bone NIH | 0.58 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
Retrospective cohort study comparing the early prognosis after surgically-treated proximal femur fragility fractures in patients affected and not affected by COVID-19.
Description: Survival at discharge day (comparison between the two groups)
Measure: Survival at discharge day (comparison between the two groups) Time: on discharge day, on average after 1 weekDescription: Length of stay (comparison between the two groups)
Measure: Length of stay (comparison between the two groups) Time: on discharge day, on average 1 weekDescription: Readmission rate (comparison between the two groups)
Measure: Readmission rate (comparison between the two groups) Time: up to 30 days after dischargeDescription: Complications rate (comparison between the two groups)
Measure: Complications rate (comparison between the two groups) Time: up to 30 days after dischargeDescription: Survival at 30 days after discharge (comparison between the two groups)
Measure: Survival at 30 days after discharge (comparison between the two groups) Time: 30 days after dischargeDescription: Routine lab exams values (comparison between the two groups)
Measure: Routine lab exams values (comparison between the two groups) Time: At admission, 1st postoperative day, 5th postoperative day, on discharge dayAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports